[Form 4] STERIS plc Insider Trading Activity
Christopher S. Holland, a director of STERIS plc (STE), reported the acquisition of 975 Career Restricted Stock Units on 08/08/2025. The filing states these Career RSUs are fully vested immediately and each represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. Following the reported transaction, Mr. Holland beneficially owns 4,964 RSU-linked ordinary shares. The Form 4 was executed by an authorized representative on 08/12/2025.
Christopher S. Holland, amministratore di STERIS plc (STE), ha segnalato l'acquisto di 975 Career Restricted Stock Units in data 08/08/2025. Dalla comunicazione risulta che queste Career RSU sono immediatamente pienamente maturate e ciascuna conferisce il diritto a ricevere una azione ordinaria STERIS sei mesi dopo la cessazione del suo incarico nel Consiglio. Dopo l'operazione, il Sig. Holland detiene di fatto 4,964 azioni ordinarie collegate a RSU. Il Modulo 4 è stato sottoscritto da un rappresentante autorizzato il 08/12/2025.
Christopher S. Holland, director de STERIS plc (STE), comunicó la adquisición de 975 Career Restricted Stock Units el 08/08/2025. La declaración indica que estas Career RSU están totalmente adquiridas de forma inmediata y que cada una otorga el derecho a recibir una acción ordinaria de STERIS seis meses después de la finalización del servicio del Director en la Junta. Tras la operación, el Sr. Holland posee de forma efectiva 4,964 acciones ordinarias vinculadas a RSU. El Formulario 4 fue firmado por un representante autorizado el 08/12/2025.
ST ERIS plc (STE)ì� ì´ì‚¬ì� Christopher S. HollandëŠ� 08/08/2025ì—� 975ê°œì˜ Career Restricted Stock Unitsì� ì·¨ë“했다ê³� ì‹ ê³ í–ˆìŠµë‹ˆë‹¤. ì‹ ê³ ì„œì— ë”°ë¥´ë©� ì� Career RSUëŠ� 즉시 ì „ì•¡ ë² ìŠ¤íŒ�ë˜ë©°, ê°� 단위ëŠ� ì´ì‚¬ê°€ ì´ì‚¬íš� ì§ë¬´ë¥� 종료í•� í›� 6개월 í›� STERIS 보통ì£� 1주를 ìˆ˜ë ¹í•� 권리ë¥� 부여합니다. ì‹ ê³ ë� 거래 ì´í›„ Holland 씨는 RSU와 ì—°ë™ë� 보통ì£� 4,964ì£�ë¥� 실질ì 으ë¡� ë³´ìœ í•˜ê³ ìžˆìŠµë‹ˆë‹¤. Form 4ëŠ� 권한 있는 대리ì¸ì� 08/12/2025ì—� 서명했습니다.
Christopher S. Holland, administrateur de STERIS plc (STE), a déclaré l'acquisition de 975 Career Restricted Stock Units le 08/08/2025. Le dépôt indique que ces Career RSU sont immédiatement entièrement acquises et que chacune donne droit à recevoir une action ordinaire STERIS six mois après la fin du mandat du Directeur au Conseil. À la suite de l'opération, M. Holland détient effectivement 4,964 actions ordinaires liées aux RSU. Le formulaire 4 a été signé par un représentant autorisé le 08/12/2025.
Christopher S. Holland, Direktor von STERIS plc (STE), meldete am 08/08/2025 den Erwerb von 975 Career Restricted Stock Units. In der Meldung heißt es, diese Career RSU seien sofort vollständig unverfallbar und berechtigten jeweils dazu, sechs Monate nach Beendigung seiner Tätigkeit im Board eine STERIS-Stammaktie zu erhalten. Nach der gemeldeten Transaktion besitzt Herr Holland wirtschaftlich 4,964 mit RSU verbundene Stammaktien. Das Formular 4 wurde von einem bevollmächtigten Vertreter am 08/12/2025 unterzeichnet.
- Reporting person acquired 975 Career Restricted Stock Units on 08/08/2025
- The Career RSUs are fully vested immediately, per the filing
- Each RSU represents the right to one ordinary share, with settlement defined (six months after board service cessation)
- None.
Insights
TL;DR: Routine director equity award recorded; vested Career RSUs defer settlement until six months after board service ends.
The Form 4 documents a director grant of 975 Career Restricted Stock Units that are noted as fully vested immediately and payable in ordinary shares six months after the director leaves board service. This structure links the award to continued board service termination timing rather than current cash or share transfers. The filing is procedural and discloses the post-termination settlement mechanism and the aggregate beneficial holdings of 4,964 RSU-linked shares.
TL;DR: Insider filing shows a modest acquisition of 975 RSUs; disclosed ownership totals and settlement terms are explicit in the Form 4.
The Form 4 reports transaction code 'A' for acquisition of 975 Career RSUs on 08/08/2025, with a reported price of $0 and total beneficial holdings of 4,964 ordinary shares tied to RSUs after the transaction. The disclosure provides clear mechanics for conversion and timing but does not indicate cash proceeds, share sales, or changes to control. From a disclosure perspective the filing is complete for the items reported.
Christopher S. Holland, amministratore di STERIS plc (STE), ha segnalato l'acquisto di 975 Career Restricted Stock Units in data 08/08/2025. Dalla comunicazione risulta che queste Career RSU sono immediatamente pienamente maturate e ciascuna conferisce il diritto a ricevere una azione ordinaria STERIS sei mesi dopo la cessazione del suo incarico nel Consiglio. Dopo l'operazione, il Sig. Holland detiene di fatto 4,964 azioni ordinarie collegate a RSU. Il Modulo 4 è stato sottoscritto da un rappresentante autorizzato il 08/12/2025.
Christopher S. Holland, director de STERIS plc (STE), comunicó la adquisición de 975 Career Restricted Stock Units el 08/08/2025. La declaración indica que estas Career RSU están totalmente adquiridas de forma inmediata y que cada una otorga el derecho a recibir una acción ordinaria de STERIS seis meses después de la finalización del servicio del Director en la Junta. Tras la operación, el Sr. Holland posee de forma efectiva 4,964 acciones ordinarias vinculadas a RSU. El Formulario 4 fue firmado por un representante autorizado el 08/12/2025.
ST ERIS plc (STE)ì� ì´ì‚¬ì� Christopher S. HollandëŠ� 08/08/2025ì—� 975ê°œì˜ Career Restricted Stock Unitsì� ì·¨ë“했다ê³� ì‹ ê³ í–ˆìŠµë‹ˆë‹¤. ì‹ ê³ ì„œì— ë”°ë¥´ë©� ì� Career RSUëŠ� 즉시 ì „ì•¡ ë² ìŠ¤íŒ�ë˜ë©°, ê°� 단위ëŠ� ì´ì‚¬ê°€ ì´ì‚¬íš� ì§ë¬´ë¥� 종료í•� í›� 6개월 í›� STERIS 보통ì£� 1주를 ìˆ˜ë ¹í•� 권리ë¥� 부여합니다. ì‹ ê³ ë� 거래 ì´í›„ Holland 씨는 RSU와 ì—°ë™ë� 보통ì£� 4,964ì£�ë¥� 실질ì 으ë¡� ë³´ìœ í•˜ê³ ìžˆìŠµë‹ˆë‹¤. Form 4ëŠ� 권한 있는 대리ì¸ì� 08/12/2025ì—� 서명했습니다.
Christopher S. Holland, administrateur de STERIS plc (STE), a déclaré l'acquisition de 975 Career Restricted Stock Units le 08/08/2025. Le dépôt indique que ces Career RSU sont immédiatement entièrement acquises et que chacune donne droit à recevoir une action ordinaire STERIS six mois après la fin du mandat du Directeur au Conseil. À la suite de l'opération, M. Holland détient effectivement 4,964 actions ordinaires liées aux RSU. Le formulaire 4 a été signé par un représentant autorisé le 08/12/2025.
Christopher S. Holland, Direktor von STERIS plc (STE), meldete am 08/08/2025 den Erwerb von 975 Career Restricted Stock Units. In der Meldung heißt es, diese Career RSU seien sofort vollständig unverfallbar und berechtigten jeweils dazu, sechs Monate nach Beendigung seiner Tätigkeit im Board eine STERIS-Stammaktie zu erhalten. Nach der gemeldeten Transaktion besitzt Herr Holland wirtschaftlich 4,964 mit RSU verbundene Stammaktien. Das Formular 4 wurde von einem bevollmächtigten Vertreter am 08/12/2025 unterzeichnet.